DEPLOYDatabase

Robot model

LIBERTY Endovascular Robotic System

Microbot Medical is a Hingham, MA-based commercial-stage medical device company (Nasdaq: MBOT) that developed the LIBERTY Endovascular Robotic System, the…

Track LIBERTY Endovascular Robotic System
Manufacturer
Microbot Medical
Form factor
surgical
Maturity
commercial
Lifecycle
active
Deployments
5
Website
ir.microbotmedical.com ↗

The verified answer

As of Aug 2026, DEPLOY verifies LIBERTY Endovascular Robotic System, a surgical by Microbot Medical (commercial): 5 verified deployments on record. 1 source back the record.

Overview

Microbot Medical is a Hingham, MA-based commercial-stage medical device company (Nasdaq: MBOT) that developed the LIBERTY Endovascular Robotic System, the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. The LIBERTY system received FDA 510(k) clearance in 2025.

Verified vs. claimed

Maturity stage
commercial(Commercially deployed with revenue-generating operations.)
Sources on file
View all sources →

Key facts

FDA cleared

LIBERTY Endovascular Robotic System; Nasdaq=MBOT

Stock

Nasdaq: MBOT

Product

LIBERTY Endovascular Robotic System

FDA clearance

510(k) (2025)

Key feature

Single-use, remotely operated

Ticker

MBOT (Nasdaq)

Category

Endovascular surgical robotics

Data & sources

Press releases

1

1 source backing this record.View all →

Pricing

No verified price is on record for LIBERTY Endovascular Robotic System. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

How DEPLOY tracks pricing

Deployments (5)

Free to use on your site, with a link back to DEPLOY.

LIBERTY Endovascular Robotic System on the deployment map

View the global map

Where LIBERTY Endovascular Robotic System is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Safety record

No incidents on record for LIBERTY Endovascular Robotic System.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (1)

  1. https://ir.microbotmedical.com/news-events/press-release

Common questions

What is LIBERTY Endovascular Robotic System?
Microbot Medical is a Hingham, MA-based commercial-stage medical device company (Nasdaq: MBOT) that developed the LIBERTY Endovascular Robotic System, the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. The LIBERTY system received FDA 510(k) clearance in 2025.
How much does LIBERTY Endovascular Robotic System cost?
LIBERTY Endovascular Robotic System's price is not publicly disclosed. DEPLOY has no verified price on record for LIBERTY Endovascular Robotic System from Microbot Medical. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is LIBERTY Endovascular Robotic System actually deployed in the real world?
Yes. LIBERTY Endovascular Robotic System is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes LIBERTY Endovascular Robotic System?
LIBERTY Endovascular Robotic System is made by Microbot Medical, based in Hingham, MA, USA, founded in 2011.
Where is LIBERTY Endovascular Robotic System deployed?
5 verified deployments of LIBERTY Endovascular Robotic System are on the DEPLOY registry, including at North Carolina, USA, Tampa, Florida, USA, Atlanta, Georgia, USA.
Can you buy LIBERTY Endovascular Robotic System?
LIBERTY Endovascular Robotic System is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
What are alternatives to LIBERTY Endovascular Robotic System?
On the DEPLOY registry, comparable surgical robots to LIBERTY Endovascular Robotic System include Edison Histotripsy System, da Vinci (and Ion), Toumai, Stryker Mako SmartRobotics.
How does LIBERTY Endovascular Robotic System compare to Edison Histotripsy System?
LIBERTY Endovascular Robotic System and Edison Histotripsy System (HistoSonics · 14 deployments) are both surgical robots on the DEPLOY registry. LIBERTY Endovascular Robotic System has 5 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is LIBERTY Endovascular Robotic System a top surgical?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, LIBERTY Endovascular Robotic System ranks in roughly the top 22% of surgical models tracked by the registry.
What is LIBERTY Endovascular Robotic System's maturity stage?
LIBERTY Endovascular Robotic System is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
Is LIBERTY Endovascular Robotic System safe?
LIBERTY Endovascular Robotic System has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 1 source (1 primary) · last reviewed 2026-07-12

Verification posture

Verified

High confidence

Review state

Stable

Last reviewed 2026-07-12

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

1
primary-company-ir
Company IR disclosure

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for LIBERTY Endovascular Robotic System.

Recent coverage

LIBERTY Endovascular Robotic System in third-party press

Microbot Medical Wins Surgical Robotics Industry Award for the LIBERTY Endovascular Robotic System

Jun 25, 2026

Microbot Medical Receives FDA 510(k) Clearance for Its LIBERTY Endovascular Robotic System

Sep 8, 2025

Microbot Medical Receives FDA 510(k) Clearance for Its LIBERTY Endovascular Robotic System

Jun 1, 2025